I planned to develop Proliposomes and provide via oral route to improve the bio-availability of the drug which is extensively metabolized in the liver. I found certain literature stating it can avoid first pass metabolism. If anyone is aware about this can share their views.

Thanks in advance. 

More Ramkumar Ponnuraj's questions See All
Similar questions and discussions